Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA from Pharmacy Times - Journalist Profile

	Profile	Recent Articles on Subject
1	Brooke Adams, PharmD, BCOP Pharmacy Times	Final Thoughts - about 1 month ago Personalizing Treatments and Patient Education - about 2 months ago Pharmacists’ Roles on the Multidisciplinary Team - about 2 months ago Pharmacists’ Roles in MM Management - about 2 months ago SC vs IV Administration Methods - about 2 months ago Impact of SC Daratumumab - 2 months ago Evaluating New Data for Transplant-Eligible Patients With NDMM: PERSEUS, IsKia, and GMMG HD7 - 2 months ago Challenges in Adopting Novel Therapies - 2 months ago Real-World Considerations for New Therapies - 2 months ago Treatment Regimen Considerations - 3 months ago Impact of Transplant Eligibility on Treatment Selection - 3 months ago
2	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	Final Thoughts - about 1 month ago Personalizing Treatments and Patient Education - about 2 months ago Pharmacists’ Roles on the Multidisciplinary Team - about 2 months ago Pharmacists’ Roles in MM Management - about 2 months ago SC vs IV Administration Methods - about 2 months ago Impact of SC Daratumumab - 2 months ago Evaluating New Data for Transplant-Eligible Patients With NDMM: PERSEUS, IsKia, and GMMG HD7 - 2 months ago Challenges in Adopting Novel Therapies - 2 months ago Real-World Considerations for New Therapies - 2 months ago Treatment Regimen Considerations - 3 months ago Impact of Transplant Eligibility on Treatment Selection - 3 months ago
3	Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA Pharmacy Times	Final Thoughts - about 1 month ago Personalizing Treatments and Patient Education - about 2 months ago Pharmacists’ Roles on the Multidisciplinary Team - about 2 months ago Pharmacists’ Roles in MM Management - about 2 months ago SC vs IV Administration Methods - about 2 months ago Impact of SC Daratumumab - 2 months ago Evaluating New Data for Transplant-Eligible Patients With NDMM: PERSEUS, IsKia, and GMMG HD7 - 2 months ago Challenges in Adopting Novel Therapies - 2 months ago Real-World Considerations for New Therapies - 2 months ago Treatment Regimen Considerations - 3 months ago Impact of Transplant Eligibility on Treatment Selection - 3 months ago